These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27146692)

  • 1. Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India.
    Tamayo A; Shah SR; Bhatia S; Chowdhury A; Rao PN; Dinh P; Knox SJ; Gaggar A; Subramanian GM; Mohan VG; Sood A; Mehta R; Sarin SK
    Hepatol Int; 2016 Nov; 10(6):988-995. PubMed ID: 27146692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey.
    Kim HS; Yang JD; El-Serag HB; Kanwal F
    J Viral Hepat; 2019 May; 26(5):596-602. PubMed ID: 30629790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-optimal Testing and Awareness of HCV and HBV Among High Risk Individuals at an Underserved Safety-Net Hospital.
    Wong RJ; Campbell B; Liu B; Baden R; Bhuket T
    J Community Health; 2018 Feb; 43(1):65-69. PubMed ID: 28647860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea.
    Shin A; Cho ER; Kim J; Sung J; Park KW; Lim MK; Shin HR
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1894-8. PubMed ID: 19454614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C virus infection: it is not only about the liver.
    Vigani AG; Tozzo R; Quezada A; Diaz AC; Mendes L; Lopes I; Riberio E; Espindola GM; Lopes FP; Petoilho EC; Queiroz JL; Castro HM
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):313-8. PubMed ID: 23719563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India.
    Saravanan S; Velu V; Kumarasamy N; Shankar EM; Nandakumar S; Murugavel KG; Balakrishnan P; Solomon SS; Solomon S; Thyagarajan SP
    Int J Infect Dis; 2008 Sep; 12(5):513-8. PubMed ID: 18455943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
    Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
    Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relations between IL-2-330 polymorphisms and the outcome of hepatitis B and/or hepatitis C virus infection].
    Gao QJ; Liu DW; Zhang SY; Wu LH; Jia M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep; 31(9):1041-5. PubMed ID: 21162873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of hepatitis B knowledge and stigma among chronically infected patients and uninfected persons in Beijing, China.
    Huang J; Guan ML; Balch J; Wu E; Rao H; Lin A; Wei L; Lok AS
    Liver Int; 2016 Nov; 36(11):1595-1603. PubMed ID: 27206379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.
    Papatheodoridis GV; Tsochatzis E; Hardtke S; Wedemeyer H
    Liver Int; 2014 Nov; 34(10):1452-63. PubMed ID: 24750532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
    Kazankov K; Barrera F; Møller HJ; Bibby BM; Vilstrup H; George J; Grønbaek H
    Hepatology; 2014 Aug; 60(2):521-30. PubMed ID: 24623375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey.
    Papatheodoridis G; Sypsa V; Kantzanou M; Nikolakopoulos I; Hatzakis A
    J Viral Hepat; 2015 Apr; 22(4):409-15. PubMed ID: 25209157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C.
    Weinstein AA; Kallman Price J; Stepanova M; Poms LW; Fang Y; Moon J; Nader F; Younossi ZM
    Psychosomatics; 2011; 52(2):127-32. PubMed ID: 21397104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S; Wysocki M; Kołtan A; Swiatkiewicz V; Styczyński J; Debski R; Balcar-Boroń A
    Med Sci Monit; 2002 Apr; 8(4):CR274-9. PubMed ID: 11951070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
    Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.